- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Nanologica AB: Nanologica Publishes Information Document Regarding Directed Share Issues and Rights Issue | 267 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 05.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 05.03.2026 | 290 | Xetra Newsboard | Das Instrument 4YD SE0005454873 NANOLOGICA AB EQUITY wird cum Kapitalmassnahme gehandelt am 05.03.2026 und ex Kapitalmassnahme am 06.03.2026 The instrument 4YD SE0005454873 NANOLOGICA AB EQUITY is traded... ► Artikel lesen | |
| 04.03. | Nanologica AB: Bulletin From The Extraordinary General Meeting In Nanologica AB (publ) | 256 | GlobeNewswire (Europe) | Nanologica AB (publ) ("Nanologica" or the "Company") held an extraordinary general meeting today at which the following resolutions were passed.
For more detailed information on the content of the resolutions... ► Artikel lesen | |
| NANOLOGICA Aktie jetzt für 0€ handeln | |||||
| 26.02. | Nanologica AB: Year-End Report 2025 Nanologica AB (publ) | 370 | GlobeNewswire (Europe) | FINANCIAL SUMMARYNet sales for the fourth quarter amounted to SEK 5,205 thousand (6,715) and for the full year to SEK 21,127 thousand (14,538)Operating loss for the quarter amounted to SEK -15,706 thousand... ► Artikel lesen | |
| 02.02. | Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon | 403 | GlobeNewswire (Europe) | Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity... ► Artikel lesen | |
| 30.01. | Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica | 2 | Contract Pharma | ||
| 30.01. | Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million | 897 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 29.01. | Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica | 597 | GlobeNewswire (Europe) | Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of... ► Artikel lesen | |
| 23.10.25 | Nanologica AB: Interim Report Q3 2025 Nanologica AB (publ) | 613 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 2,843 thousand (611) and for the nine-month period to SEK 15,930 thousand (7,822)Operating loss for the quarter amounted to SEK -10... ► Artikel lesen | |
| 22.10.25 | Nanologica AB: Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China | 405 | GlobeNewswire (Europe) | Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order relates to sampling NLAB Saga® to pharmaceutical manufacturers.
"This... ► Artikel lesen | |
| 01.10.25 | Nanologica AB: Nanologica AB (publ) Enters the Insulin Market in China | 350 | GlobeNewswire (Europe) | Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media NLAB Saga®. The customer is an insulin manufacturer... ► Artikel lesen | |
| 16.07.25 | The observation status for Nanologica AB (publ) is removed | 905 | GlobeNewswire | On May 23, 2025, the shares in Nanologica AB (publ) were given observation status with reference to a public takeover offer from Flerie Invest AB to the shareholders in Nanologica AB (publ).
Today... ► Artikel lesen | |
| 16.07.25 | Flerie AB: Flerie AB's subsidiary Flerie Invest AB announces final outcome of the mandatory cash offer to the shareholders of Nanologica AB (publ) | 684 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE... ► Artikel lesen | |
| 10.07.25 | Nanologica AB: Interim Report Q2 2025 Nanologica AB (publ) | 662 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the second quarter amounted to SEK 2,335 thousand (2,174) and for the first half of the year to SEK 13,087 thousand (7,211)Operating loss for the quarter amounted to... ► Artikel lesen | |
| 13.06.25 | Nanologica AB: Statement From The Board Of Directors Of Nanologica AB (publ) Regarding The Mandatory Bid From Flerie Invest Ab | 741 | GlobeNewswire (Europe) | The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") unanimously recommends the shareholders of Nanologica not to accept the mandatory cash offer made by Flerie Invest AB ("Flerie")... ► Artikel lesen | |
| 12.06.25 | Flerie AB: Flerie's portfolio company Nanologica has received its first U.S. order | 913 | GlobeNewswire (Europe) | Stockholm, Sweden, June 12, 2025. Flerie AB's (publ) portfolio company Nanologica has announced that the company has secured an order for its silica-based purification media, NLAB Saga®, from a new... ► Artikel lesen | |
| 23.05.25 | Nanologica AB (publ) ges observationsstatus / Nanologica AB (publ) receives observation status | 1.361 | GlobeNewswire | Idag, den 23 maj 2025, offentliggjorde Flerie Invest AB ett budpliktsbud till övriga aktieägare i Nanologica AB (publ).
Enligt regelverket för Nasdaq Stockholm kan en emittent ges observationsstatus... ► Artikel lesen | |
| 23.05.25 | Nanologica AB: Comment from the Board of Nanologica AB (publ) Regarding the Mandatory Bid from Flerie Invest AB | 1.056 | GlobeNewswire (Europe) | Nanologica AB's (publ) ("Nanologica") main owner Flerie Invest AB ("Flerie") has today, May 23, 2025, made a mandatory cash offer of SEK 1.00 per share to the shareholders of Nanologica (the "Offer").... ► Artikel lesen | |
| 23.05.25 | Flerie AB: Flerie Invest AB announces a mandatory cash offer to the shareholders of Nanologica AB (publ) | 1.068 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE... ► Artikel lesen | |
| 22.05.25 | Nanologica AB: Bulletin from the AGM 2025 Nanologica AB (publ) | 1.066 | GlobeNewswire (Europe) | Nanologica AB (publ) today May 22, 2025 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted.
Adoption of the income statement and balance sheet, disposition... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,280 | -2,23 % | Vorläufige Umsatzzahlen für 2025 bei Formycon und 'Anpassungen'der Prognose | Die Formycon AG erwartet für 2025 Konzernumsatzerlöse von ca. 45 Mio. EUR, muss jedoch ihre Prognose neu zubereiten. Auf Basis vorläufiger und noch nicht testierter Zahlen rechnet die Formycon (Aktie:... ► Artikel lesen | |
| KOPIN | 1,900 | -2,56 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| RIBER | 5,750 | -1,88 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| ONTO INNOVATION | 159,00 | -4,79 % | ONTO INNOVATION INC. - 10-K, Annual Report | ||
| VEECO INSTRUMENTS | 27,400 | 0,00 % | Veeco Instruments Inc. (VECO) Announces Placement of Orders for Multiple Lumina Metal Organic Chemical Vapor Deposition Systems and Spector Ion Beam Sputtering Optical Coating Systems | ||
| SOLESENCE | 1,015 | -1,46 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| NANOVIRICIDES | 1,000 | -1,96 % | NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete | SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot... ► Artikel lesen | |
| CANATU | 8,360 | +13,90 % | Canatu Oyj: Canatu's Financial Statements Bulletin 2025 | Canatu Plc Company announcement 3 March 2026 at 9:00 a.m. EET
Canatu's Financial Statements Bulletin 2025
This is a summary of Canatu Plc's Financial Statements Bulletin for the year 2025. The complete... ► Artikel lesen | |
| DOTZ NANO | 0,020 | 0,00 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| GAUZY | 0,508 | +1,72 % | GAUZY LTD: Gauzy Announces Initiation of a Call for Public Tenders for Buyers or Investors | TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announces the initiation... ► Artikel lesen | |
| OBDUCAT | 0,003 | -46,88 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 4,220 | +20,57 % | Acacia Research signals $2M annualized cost savings from Deflecto plant consolidation while maintaining $340M cash and securities | ||
| NVE | 58,50 | -3,31 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,540 | +2,86 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 16.02.2026 | Das Instrument OYS US68162K1060 OLYMPIC STEEL EQUITY wird cum Kapitalmassnahme gehandelt am 16.02.2026 und ex Kapitalmassnahme am 17.02.2026 The instrument OYS US68162K1060 OLYMPIC STEEL EQUITY is traded... ► Artikel lesen | |
| LAMPETIA | 0,094 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen |
Das Unternehmen NANOLOGICA AB kann der Branche Nanotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -6,98 % bei einem Aktienkurs von 0,008 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOLOGICA AB finden Sie auf Wallstreet Online.